Professor Jagat R. Kanwar has received his PhD in 1992 from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Before joining Deakin University, Australia, in 2006, he was a Senior Scientist in the University of Auckland, Auckland, New Zealand. Dr Kanwar, group leader of the Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research has a national and international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. Currently, his major field if interest are nanomedicine based delivery systems for therapy/diagnosis, biotechnology, protein engineering of therapeutic proteins and find their mechanism of actions. He has successfully completed his Administrative responsibilities as Head of Nanomedicine in the Centre for Biotechnology and Interdisciplinary Biosciences (BioDeakin), Institute for Technology & Research Innovation (ITRI), Deakin University. He is serving as an editorial member of several reputed journals in the field of Biochemistry, Nanobiotechnology, Nanomedicine, Cancer and Immunology. He has authored more than 85 research articles, 12 book chapters and 2 books, and secured more than 10 patents. He is the Member of Editorial Board for 12 international journals and a nominated member of more than 18 national and international societies including American Nano Society and American Society of Nanomedicine.
Nanomedicine based delivery systems for therapy/diagnosis, biotechnology, protein engineering of therapeutic proteins and their mechanism of actions.